RheumaVision 2: your chance to shine in London at EULAR 2026! Hurry up!

Dear EMEUNET Community,

EULAR is now accepting applications for RheumaVision 2026 until 15th December 2025!

RheumaVision is your chance to shine — think of it as the Eurovision Song Contest of the young rheumatology community, celebrating creativity, presentation skills, and innovative knowledge sharing.

Represent your country by creating a powerful 3–5 minute video on a key rheumatology topic (excluding your own research).

Why Join RheumaVision?

• Gain Recognition from Top Experts – Boost your visibility across the rheumatology field.
• Expand Your Network – Connect with peers and leaders throughout the EULAR community.
• Win Prizes! – Selected finalists will present their video at the EULAR 2026 Congress and receive:
•Congress registration and on-demand access
•Accommodation in London
• A one-off payment of €350 for travel and living expenses (transferred after the Congress)

Eligibility

You must be:
• An EMEUNET member (young rheumatologist, researcher, HPR, or PAED), or
• A young PARE member,
and under 40 years old.

Assessment Criteria

Videos will be evaluated on:
Relevance – Scientific accuracy – Clarity – Creativity – Inspiration

As in Eurovision, only one contestant per country will move forward — giving you the chance to shine on an international stage.

Competition Stages

• National Stage:
Country Liaisons (or a designated EMEUNET member) will select the top submissions from each country.

• Semifinals:
Selected videos will be reviewed through public voting + EULAR jury assessment.
The top six participants will be invited to present live at EULAR 2026.

• Finals:
Winners will be determined through a combination of public voting and jury evaluation.

📅 Application deadline: 15th December 2025

🔗 Apply here: RheumaVision 2026 – EMEUNET Community – Jira Service Management

Submit your application and video today!
We are looking for claritycreativity, and a passion for rheumatology.
Further details on submission format and technical guidelines will be provided upon application.

With best wishes,

The EMEUNET RheumaVision Team

Leave a Reply